Spinifex Pharmaceuticals
Clinical-stage biotechnology company specializing in the development of products for the treatment of pain.
Launch date
Employees
Market cap
-
Enterprise valuation
$200m (Public information from Jun 2015)
Stamford Connecticut (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
AUD3.3m | Series A | ||
* | AUD12.0m | Series A | |
$19.0m | Series B | ||
$45.0m | Series C | ||
$200m Valuation: $200m | Acquisition | ||
| Total Funding | $73.9m | ||